ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium
There is strong epidemiologic evidence indicating that common genetic variability could be implicated in pancreatic cancer risk and, to date, various loci have been proposed. In particular, there is increasing evidence of the involvement of ABO gene variability and pancreatic cancer risk. In a large...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 12, 2013
|
| In: |
Oncology reports
Year: 2013, Jahrgang: 29, Heft: 4, Pages: 1637-1644 |
| ISSN: | 1791-2431 |
| DOI: | 10.3892/or.2013.2285 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3892/or.2013.2285 Verlag, lizenzpflichtig, Volltext: https://www.spandidos-publications.com/10.3892/or.2013.2285 |
| Verfasserangaben: | Cosmeri Rizzato, Daniele Campa, Raffaele Pezzilli, Pavel Soucek, William Greenhalf, Gabriele Capurso, Renata Talar-Wojnarowska, Anette Heller, Krzysztof Jamroziak, Kay-Tee Khaw, Tim J. Key, Franco Bambi, Stefano Landi, Beatrice Mohelnikova-Duchonova, Ludmila Vodickova, Markus W. Büchler, Peter Bugert, Pavel Vodicka, John P. Neoptolemos, Jens Werner, Jörg D. Hoheisel, Andrea S. Bauer, Nathalia Giese and Federico Canzian |